Eosinophil Peroxidase (EPX) (Middle Region) Peptide
EPX
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN976400
Quick Overview for Eosinophil Peroxidase (EPX) (Middle Region) Peptide (ABIN976400)
Target
EPX
(Eosinophil Peroxidase (EPX))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-EPX antibody (Catalog #: ARP41752_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- EPX (Eosinophil Peroxidase (EPX))
-
Background
-
EPX belongs to the peroxidase family, XPO subfamily. Defects in EPX are the cause of eosinophil peroxidase deficiency (EPD).
Alias Symbols: EPO, EPP, EPX-PEN
Protein Size: 715 -
Molecular Weight
- 53 kDa
-
Gene ID
- 8288
-
NCBI Accession
- NM_000502, NP_000493
-
UniProt
- P11678
Target
-
You are here:
